Trial
NCT03033511
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
AbbVie
Collaborators
—
Condition
Small Cell Lung Cancer
Intervention
Placebo for dexamethasone
Why stopped
Independent Data Monitoring Committee recommendation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-29